Shockwave Medical (SWAV) has a profit margin of 20.75%, above the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2024
Trailing 12 months ending Mar 2024
As of the most recent data (March 2024), SWAV shows a profit margin of 20.75%. That compares with 43.18% in the prior-year period — down 51.9% year over year. That is above the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SWAV's profit margin is now 20.75% (was 43.18%) — a 51.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shockwave Medical is outperforming or lagging.
The Healthcare sector average profit margin is about 14.34%. Shockwave Medical is at 20.75%, which is higher that average. That is roughly 44.6% above the sector mean. Use the comparison chart on this page to see how SWAV stacks up against individual peers as well.
That compares with 43.18% in the prior-year period — down 51.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Shockwave Medical with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Shockwave Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 20.75%) with ownership activity and broader fundamentals.